As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
The Danish pharma giant has been hit by trimmed growth forecasts, pricing pressure, rising competition from Eli Lilly (LLY), mass layoffs, dramatic leadership changes, and even a high-profile public bidding war with U.S. rival Pfizer (PFE). Although Novo's blockbuster Ozempic enjoyed a four-year head start over Lilly's Mounjaro, Lilly has now pulled ahead in U.S. prescriptions. Novo's struggles to keep up with demand also allowed compounding pharmacies to step in, chipping away at its market share and making 2025 one of its toughest years yet. But just as investor confidence was wearing thin, Novo delivered what felt like an early Christmas gift. On Dec.22, the Wegovy manufacturer became the first drugmaker to win FDA approval for a GLP-1 pill for weight loss, a milestone some analysts called a “redemption for investors” following the stock's worst year on record. Super Micro Computer Stock Tumbles, But Investors are Piling into Its Call Options - Time to Buy SMCI? A $61 Billion
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree [Yahoo! Finance]Yahoo! Finance
- ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly [Yahoo! Finance]Yahoo! Finance
- Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? [Yahoo! Finance]Yahoo! Finance
- Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies [Yahoo! Finance]Yahoo! Finance
- 5 Big Drug Stocks That May Continue to Outperform in 2026 [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/23/25 - Form 144
- 12/16/25 - Form 4
- 12/16/25 - Form 4
- LLY's page on the SEC website